These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2521783)

  • 21. Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients.
    Vila AT; Puig L; Fernández-Figueras MT; Laiz AM; Vidal D; Alomar A
    Br J Dermatol; 2005 Aug; 153(2):417-23. PubMed ID: 16086759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic T lymphocytes and phenotypically abnormal epidermal dendritic cells in fixed cutaneous eruptions.
    Murphy GF; Guillén FJ; Flynn TC
    Hum Pathol; 1985 Dec; 16(12):1264-71. PubMed ID: 2415442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary damage associated with sodium aurothiomalate therapy.
    Gould PW; McCormack PL; Palmer DG
    J Rheumatol; 1977; 4(3):252-60. PubMed ID: 411928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Disseminated lung nodules with blood eosinophilia caused by gold therapy (author's transl)].
    Sone S; Higashihara T; Morimoto S; Yokota K; Ikezoe J; Kawanishi K; Kitano Y
    Rinsho Hoshasen; 1979 Apr; 24(4):489-93. PubMed ID: 156271
    [No Abstract]   [Full Text] [Related]  

  • 25. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.
    Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D
    J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative toxicity of gold preparations in treatment of rheumatoid arthritis.
    Lawrence JS
    Ann Rheum Dis; 1976 Apr; 35(2):171-3. PubMed ID: 821403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurologic complications induced by gold treatment.
    Schlumpf U; Meyer M; Ulrich J; Friede RL
    Arthritis Rheum; 1983 Jul; 26(7):825-31. PubMed ID: 6409125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate.
    McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN
    Med J Aust; 1984 Sep; 141(6):349-51. PubMed ID: 6438454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An investigation of the action of disease modifying antirheumatic drugs on the rheumatoid synovial membrane: reduction in T lymphocyte subpopulations and HLA-DP and DQ antigen expression after gold or penicillamine therapy.
    Walters MT; Smith JL; Moore K; Evans PR; Cawley MI
    Ann Rheum Dis; 1987 Jan; 46(1):7-16. PubMed ID: 3101623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchiolo-alveolitis with pulmonary basal lamina injury in a rheumatoid patient during gold treatment.
    Pääkkö P; Sutinen S; Anttila S; Autio-Harmainen H; Sormunen R; Hakala M; Jouppila J
    Pathol Res Pract; 1988 Feb; 183(1):46-53. PubMed ID: 3129704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vivo effect of triethylphosphine gold (auranofin), sodium aurothiomalate and azathioprine on lymphocyte subsets of patients with rheumatoid arthritis.
    Pedersen BK; Abom B
    Allergy; 1988 Jul; 43(5):396-8. PubMed ID: 2970811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate.
    Jessop JD; Johns RG
    Ann Rheum Dis; 1973 May; 32(3):228-32. PubMed ID: 4268483
    [No Abstract]   [Full Text] [Related]  

  • 33. Gold-associated lymphadenopathy in a patient with rheumatoid arthritis. Histologic and scanning electron microscopic features.
    Rollins SD; Craig JP
    Arch Pathol Lab Med; 1991 Feb; 115(2):175-7. PubMed ID: 1899556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for immunostimulatory effects of intramuscular gold in patients with rheumatoid arthritis: correlation with skin reactions.
    Ernestam S; Lampa J; Rogberg S; Rönnelid J; Klareskog L; Hafström I
    J Rheumatol; 2003 Aug; 30(8):1748-55. PubMed ID: 12913930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypersensitivity to gold in gold sodium thiomalate-induced dermatosis.
    Räsänen L; Kaipiainen-Seppänen O; Myllykangas-Luosujärvi R; Käsnänen T; Pollari P; Saloranta P; Horsmanheimo M
    Br J Dermatol; 1999 Oct; 141(4):683-8. PubMed ID: 10583116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
    Kean WF; Lock CJ; Howard-Lock HE; Buchanan WW
    Arthritis Rheum; 1982 Aug; 25(8):917-22. PubMed ID: 6214261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum gold. II. Levels in rheumatoid arthritis.
    Rubinstein HM; Dietz AA
    Ann Rheum Dis; 1973 Mar; 32(2):128-32. PubMed ID: 4266407
    [No Abstract]   [Full Text] [Related]  

  • 38. Diffuse pulmonary injury associated with gold treatment.
    Winterbauer RH; Wilske KR; Wheelis RF
    N Engl J Med; 1976 Apr; 294(17):919-21. PubMed ID: 130554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Panhypogammaglobulinaemia caused by gold therapy.
    Pearson SL; Stewart IC; Kellett RJ
    Scott Med J; 1988 Oct; 33(5):343-4. PubMed ID: 3147512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gold in the dermis following chrysotherapy: histopathology and microanalysis.
    Keen CE; Brady K; Kirkham N; Levison DA
    Histopathology; 1993 Oct; 23(4):355-60. PubMed ID: 7905458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.